Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...

Galway, Ireland-based Medtronic plc (MDT) develops, manufactures, and sells device-based medical therapies to healthcare ...

The pink, white and red blob of tissue quivers in a vat of clear goop about the size of a kitchen sink. Graduate students ...

How mission plus performance can lead to sustainable success.

In December, YNHH integrated the newly FDA-approved Medtronic VitalFlow ECMO System and first used it to transfer a patient ...

Bogle, Medtronic’s head of medical affairs for digital surgery, also discussed the company’s plans to train surgeons for its ...

The company will keep the systems on the market but is asking providers to check devices for visible cracks and return ...

Medtronic is capturing demand for its cutting-edge solutions, as recent product launches emerge to drive new growth. With the ...

Medical device specialist Medtronic ( MDT 1.05%) has long been a solid dividend stock -- and it has upped its payout for ...

In the closing of the recent trading day, Medtronic (MDT) stood at $91.69, denoting a +0.79% change from the preceding trading day.

Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 2025 on Tuesday, February 18, 2025. A ...